Nuevas estrategias terapéuticas para el neuroblastoma basadas en el uso de microRNAs

Translated title of the contribution: Novel micro RNA-based therapies for the treatment of neuroblastoma

Ariadna Boloix, Laia París-Coderch, Aroa Soriano, Josep Roma, Soledad Gallego, Josep Sánchez de Toledo, Miguel F. Segura*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Neuroblastoma (NB) is the most common solid tumour in children and adolescents, and accounts for up to 15% of all cancer deaths in this group. It originates in the sympathetic nervous system, and its behaviour can be very aggressive and become resistant to current treatments. A review is presented, summarising the new alternative therapies based on epigenetics, i.e., modulators of gene expression, such as microRNAs and their potential application in the clinical practice of NB treatment.

Translated title of the contributionNovel micro RNA-based therapies for the treatment of neuroblastoma
Original languageSpanish
Pages (from-to)109.e1-109.e6
JournalAnales de Pediatria
Volume85
Issue number2
DOIs
Publication statusPublished - 1 Aug 2016

Fingerprint Dive into the research topics of 'Novel micro RNA-based therapies for the treatment of neuroblastoma'. Together they form a unique fingerprint.

Cite this